BlueRock Therapeutics Empresa reivindicada
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
consulte Mais informação
To date, the talent acquisition team at BlueRock have been great. I was told from the beginning about the role, potential compensation and the interview process. The only area that may be helpful is to share next steps as I finished my interviews and now do not know what is next or timing.
Other Employee Reviews for BlueRock Therapeutics
×